Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Alnylam Pharmaceuticals Inc shares valued at $14,988,720 were sold by Garg Pushkal on Jan 27 ’25. At $285.00 per share, Garg Pushkal sold 52,592 shares. The insider’s holdings dropped to 11,989 shares worth approximately $3.32 million following the completion of this transaction.
Also, Garg Pushkal purchased 52,592 shares, netting a total of over 14,988,720 in proceeds.
Before that, SHARP PHILLIP A had sold 11,250 shares from its account. In a trade valued at $3,093,750, the Director traded Alnylam Pharmaceuticals Inc shares for $275.00 each. Upon closing the transaction, the insider’s holdings decreased to 11,250 shares, worth approximately $0.0.
As published in a research note from Wolfe Research on November 12, 2024, Alnylam Pharmaceuticals Inc [ALNY] has been rated down from a Peer perform to an Underperform. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid October. As of August 16, 2024, Goldman has increased its “Neutral” rating to a “Buy” for ALNY. Earlier on February 16, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for ALNY stock which previously was a “a Buy”.
Analyzing ALNY Stock Performance
During the last five days, there has been a surge of approximately 0.59%. Over the course of the year, Alnylam Pharmaceuticals Inc shares have jumped approximately 17.79%. Shares of the company reached a 52-week high of $287.22 on 01/27/25 and a 52-week low of $231.00 on 01/06/25. A 50-day SMA is recorded $249.60, while a 200-day SMA reached $233.85. Nevertheless, trading volume fell to 0.56 million shares from 0.38 million shares the previous day.
Support And Resistance Levels for Alnylam Pharmaceuticals Inc (ALNY)
According to the 24-hour chart, there is a support level at 270.99, which, if violated, would cause prices to drop to 264.81. In the upper region, resistance lies at 281.35. The next price resistance is at 285.53. RSI (Relative Strength Index) is 64.24 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 14.20, which suggests the price will increase in the coming days. Percent R is at 18.49%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
